
BERKELEY, Calif. and VANCOUVER, British Columbia, June 21, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics ...

Birinapant Shows No Activity in Randomized Phase 2 MDS Study SHAPE Shows Clinical Benefit ...

BEVERLY, Mass., Feb. 16, 2017 (GLOBE NEWSWIRE) -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a ...
Click to continue to site. Closing